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ABSTRACTSConclusions: All patients should be risk stratiﬁed for post median ster-
notomy wound infections.
In patients with signiﬁcant risk factors and infected sternal wound
dehiscence combined plastic and cardiothoracic surgical input should be
undertaken from the outset.
Aggressive and early one stage debridement and ﬂap coverage should be
considered in serious sternal wound infections associated with dehiscence
as it may negate the need for multiple debridements and prolonged
vacuum therapy.
0614: SYNCHRONOUS CAROTID ENDARTERECTOMY FOR
ASYMPTOMATIC CAROTID STENOSIS AND CORONARY ARTERY BYPASS
GRAFTING IN PATIENTS WITH CONCOMITANT DISEASE - A
LITERATURE REVIEW
Frances Burrell. Glasgow Royal Inﬁrmary, Glasgow, UK
Aims: This literature review investigates the outcomes of synchronous
coronary artery bypass grafting (CABG) and carotid endarterectomy
(CEA) for concomitant disease in neurologically asymptomatic
patients.
Methods: An electronic OVID Medline database search using the
following criteria: "asymptomatic", "carotid stenosis", "carotid endarter-
ectomy", "CEA", "coronary artery bypass", "CABG" gave a total of 56 arti-
cles. Stroke and mortality rates were calculated and compared to CABG
alone in patients with carotid stenosis. Fishers exact test was used to
calculate signiﬁcance.
Results: Incidence of stroke was signiﬁcantly less in asymptomatic
patients undergoing synchronous surgery compared to symptomatic
patients, 1.7% versus 13.2%, risk 0.13 (95%conﬁdence interval 0.08-0.21,
P¼<0.0001). There was a small signiﬁcant decrease in stroke risk in
patients undergoing synchronous surgery compared to CABG alone, 3.4%
versus 5.8% , risk 0.92 (CI¼ 0.86-0.99, P¼0.0123), but this was insigniﬁcant
when limited to asymptomatic patients. There was a trend of increased
mortality in symptomatic patients and in synchronous surgery which was
not statistically signiﬁcant.
Conclusions: This study suggests synchronous surgery decreases stroke
risk in patients with carotid stenosis compared to CABG alone, but
mortality beneﬁt and beneﬁt to asymptomatic patients remains unclear.
Neurologically symptomatic patients have worse outcomes compared to
those with asymptomatic carotid stenosis.
0892: WEIGHT REDUCTION PRIOR TO ELECTIVE CORONARY
REVASCULARIZATION IN EXTREMELY OBESE PATIENTS IMPROVES
CLINICAL OUTCOMES
Remananda K. Pai, Natasha Prior, Christopher M.R. Satur. University
Hospital North Staffordshire, Stoke on Trent, UK
Introduction: 20% of patients undergoing coronary revascularization
[CABG] in the UK are obese, with associated co-morbidities including
diabetes, hypercholesterolemia poor mobility, and smoking. They present
a high risk for CABG. We examined the impact of diligent preoperative risk
modiﬁcation on postoperative outcomes.
Methods: We instituted a closely monitored regimen of risk reduction
focusing on weight loss, cessation of smoking and diabetic control, in
extremely obese patients [BMI>40] requiring elective CABG [Group WL]
and examined their outcome compared to less obese patients outside the
study group [Group OE]. Kruskal Wallis and Anova method was used for
statistical analysis.
Results: A 8.9% weight loss was achieved safely in the 13 patients [Group
WL] over 202 days, with a fall in BMI from 43.9 [+ 3.7] to 40.1[+3.4]. Four
patients quit smoking and tight glycemic control was achieved in 8 dia-
betics before surgery. In spite of the poorer patient proﬁle, patients in
group WL did better with lower incidence of mediastinitis, wound infec-
tion, early mobilization and hospital stay compared to Group OE.
Conclusion: Weight loss was safely achieved in extremely obese patients
before planned CABG with tangible reduction of adverse postoperative
outcomes and promises a better result in this high risk cohort of patients.
0983: THE OUTCOME OF CARDIAC SURGERY IN OCTOGENARIANS: A 13
YEAR EXPERIENCE
Ghazi Elshaﬁe, Omar Nawaytou, Taha Binesmael, Ana Lopez, Dheeraj
Mehta. University Hospital of Wales, Cardiff, UKAim: Advanced age is associated with increased risk in cardiac surgery
and more octogenarians are being referred for interventional procedures
for structural and ischemic heart disease. The aim of this study is to
evaluate our surgical outcome in octogenarians following cardiac
surgery.
Methods: Between January 1998 and May 2011, we identiﬁed 530 octo-
genarians who underwent cardiac surgery. The mean age was 82.3 +/- 2.4
years with a logistic EuroSCORE of 16.39 +/- 14.63. 135 patients (25.5%)
underwent isolated coronary artery bypass grafting (CABG), 357 patients
(67.3%) had aortic or mitral valve procedures.
Results: The in-hospital mortality was 6.0%. Major complications included
stroke in 0.8%, new haemoﬁlteration in 9.1% and permanent pace maker
insertion in 5.8% of patients respectively. Median postoperative staywas 13
days. The overall actuarial survival at 1, 3 and 5 years was 87.4%, 80.0% and
75.2% respectively. The actuarial survival at 5 years for the isolated CABG
group, aortic valve replacement group and mitral valve group was 82.8%,
74.7% and 74.0% respectively.
Conclusion: In our experience, cardiac surgery in octogenarians has
excellent early and long-term survival. Morbidity rates are acceptable. We
conclude that cardiac surgery should not be discounted in octogenarians
on the basis of age alone.
1004: CORONARY ARTERY BYPASS GRAFTING ON DIALYSIS-DEPENDENT
CHRONIC RENAL FAILURE PATIENTS: SHORT AND LONG-TERM
OUTCOMES, A 12 YEAR EXPERIENCE
Ghazi Elshaﬁe, Omar Nawaytou, Taha Binesmael, Ana Lopez, Dheeraj
Mehta. University Hospital of Wales, Cardiff, UK
Aim: Performing coronary artery bypass graft surgery (CABG) on dialysis-
dependent end-stage renal disease patients is still a subject for debate. This
study focuses on the short and long term outcomes of dialysis-dependent
patients undergoing CABG.
Methods: Between October 1998 and December 2010, we identiﬁed 65
dialysis dependent patients who underwent CABG in our institution. The
mean logistic EuroSCORE was 17.07 +/- 20.62. 38 patients (58.5%) under-
went isolated CABG and 27 patients (41.5%) had concomitant procedures.
Results: The total in-hospital mortality was 7.7%. Major complications
included reintubation in 4.6% of patients. None of the patients had new
post-operative stroke. The median postoperative stay was 14 days. The
overall actuarial survival at 1, 3 and 5 years was 80.0%, 64.3% and 49.8%
respectively. The actuarial survival at 5 years for the isolated CABG group,
aortic valve replacement group and mitral valve group was 51.8%, 52.5%
and 40.4% respectively.
Conclusion: Cardiac surgery can be performed in end stage renal disease
with acceptable morbidity and mortality. The relatively decreased long
term survival is only a reﬂection of their high natural attrition state and
cardiac surgery should not be discounted solely on this foundation.
1065: ANTIPLATELET THERAPY FOLLOWING CORONARY ARTERY
BYPASS GRAFT SURGERY
Amir Sepehripour, Nikolaos Koumallos. Wythenshawe Hospital,
Manchester, UK
Aim: The most recent American College of Cardiology Foundation/Amer-
ican Heart Association guidelines for coronary artery bypass graft surgery
(CABG) recommend the initiation of Aspirin (100-325mg) within 6-hours
post-operatively and indeﬁnite continuation, supported by class 1A
evidence. This study aimed to evaluate adherence to these guidelines in
our cardiac unit.
Method: A retrospective analysis of 100 consecutive patients undergoing
CABG was conducted, analysing antiplatelet agents, dosing and timing
of administration. The ﬁndings and recommendations were presented
at local level. A prospective analysis of a further 100 consecutive
patients undergoing CABG was conducted, analysing the above primary
outcomes.
Results: The retrospective analysis revealed the following therapies:
Aspirin 75mg-73%, Clopidogrel 75mg-5%, Aspirin+Clopidogrel 75mg-15%
and Aspirin 300mg-7%. Initiation of therapy within 6-hours was not
observed in any patient. The prospective analysis revealed the following
therapies: Aspirin 75mg-61%, Clopidogrel 75mg-4%, Aspirin+Clopidogrel
75mg-7% and Aspirin 300mg-28%. Initiation of therapywithin 6-hours was
observed in 16%.
